Persistent pulmonary hypertension of the newborn refractory to inhaled nitric oxide treated with milrinone: A case report

Research output: Contribution to journalArticlepeer-review

Abstract

Current therapy of persistent pulmonary hypertension of the newborn (PPHN) consists of optimal ventilation, hemodynamic support and selective vasodilatation with inhaled nitric oxide (iNO). We present herein a case of PPHN non-responsive to iNO but treated successfully with a combination of iNO and intravenous milrinone, a phosphodiesterase III inhibitor. This case suggests that the drug may be a useful adjunctive treatment in the management of PPHN.

Original languageEnglish
Pages (from-to)78-80
Number of pages3
JournalTurkish Journal of Pediatrics
Volume52
Issue number1
Publication statusPublished - Jan 2010

Keywords

  • Milrinone
  • Newborn
  • Phosphodiesterase III inhibitor
  • Pulmonary hypertension

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Persistent pulmonary hypertension of the newborn refractory to inhaled nitric oxide treated with milrinone: A case report'. Together they form a unique fingerprint.

Cite this